Warimwe G
Profile: The Kenya Multi-Site Serosurveillance (KEMIS) collaboration.Kagucia EW
Voller S
Ziraba AK
Bigogo G
Munywoki PK
Makobu K
Nokes DJ
Nyagwange J
Orlendo C
Akech D
Sigilai A
Onyango C
Juma B
Herman-Roloff A
Munyua P
Apondi C
Lidechi S
Audi A
Ouma A
Aol G
Misore T
Nasimiyu C
Onyango D
Lo T
Kasera K
Jalang'o R
Kingwara L
Adetifa I
Etyang AO
Warimwe G
Agweyu A
Scott JAG
Gates Open Res, (2025). 8:60
Accumulating evidence on the long-term immunogenicity of fractional dosing for yellow fever vaccines.Juan-Giner A
Warimwe G
Lancet Infect Dis, (2024). 24:562-564
Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial.Hamaluba M
Sang S
Orindi B
Njau I
Karanja H
Kamau N
Gitonga JN
Mugo D
Wright D
Nyagwange J
Kutima B
Omuoyo D
Mwatasa M
Ngetsa C
Agoti C
Cheruiyot S
Nyaguara A
Munene M
Mturi N
Oloo E
Ochola-Oyier L
Mumba N
Mauncho C
Namayi R
Davies A
Tsofa B
Nduati EW
Aliyan N
Kasera K
Etyang A
Boyd A
Hill A
Gilbert S
Douglas A
Pollard A
Bejon P
Lambe T
Warimwe G
COVVaccine Trial Group
Wellcome Open Res, (2023). 8:182
Where do those data go? Reuse of screening results from clinical trials to estimate population prevalence of HBV infection in adults in Kilifi, Kenya.Downs LO
Campbell C
Abouyannis M
Otiende M
Kapulu M
Obiero CW
Hamaluba M
Ngetsa C
Andersson MI
Githinji G
Warimwe G
Baisley K
Scott JAG
Matthews PC
Etyang A
J Virus Erad, (2023). 9:100355
Symptom prevalence and secondary attack rate of SARS-CoV-2 in rural Kenyan households: A prospective cohort study.Gallagher KE
Nyiro J
Agoti CN
Maitha E
Nyagwange J
Karani A
Bottomley C
Murunga N
Githinji G
Mutunga M
Ochola-Oyier LI
Kombe I
Nyaguara A
Kagucia EW
Warimwe G
Agweyu A
Tsofa B
Bejon P
Scott JAG
Nokes DJ
Influenza Other Respir Viruses, (2023). 17:e13185
Pre-vaccination monocyte-to-lymphocyte ratio as a biomarker for the efficacy of malaria candidate vaccines: A subgroup analysis of pooled clinical trial data.Nyandele JP
Kibondo UA
Issa F
Van Geertruyden JP
Warimwe G
Jongo S
Abdulla S
Olotu A
PLoS One, (2023). 18:e0291244
Transmission networks of SARS-CoV-2 in Coastal Kenya during the first two waves: A retrospective genomic study.Agoti CN
Ochola-Oyier LI
Dellicour S
Mohammed KS
Lambisia AW
de Laurent ZR
Morobe JM
Mburu MW
Omuoyo DO
Ongera EM
Ndwiga L
Maitha E
Kitole B
Suleiman T
Mwakinangu M
Nyambu JK
Otieno J
Salim B
Musyoki J
Murunga N
Otieno E
Kiiru JN
Kasera K
Amoth P
Mwangangi M
Aman R
Kinyanjui S
Warimwe G
Phan M
Agweyu A
Cotten M
Barasa E
Tsofa B
Nokes DJ
Bejon P
Githinji G
Elife, (2022). 11:
Epidemiology of COVID-19 infections on routine polymerase chain reaction (PCR) and serology testing in Coastal Kenya.Nyagwange J
Ndwiga L
Muteru K
Wamae K
Tuju J
Testing Team C
Kutima B
Gitonga J
Karanja H
Mugo D
Kasera K
Amoth P
Murunga N
Babu L
Otieno E
Githinji G
Nokes DJ
Tsofa B
Orindi B
Barasa E
Warimwe G
Agoti CN
Bejon P
Ochola-Oyier LI
Wellcome Open Res, (2022). 7:69
Clinical manifestations of Rift Valley fever in humans: Systematic review and meta-analysis.Anywaine Z
Lule SA
Hansen C
Warimwe G
Elliott A
PLoS Negl Trop Dis, (2022). 16:e0010233
Assessing the Level and Determinants of COVID-19 Vaccine Confidence in Kenya.Orangi S
Pinchoff J
Mwanga D
Abuya T
Hamaluba M
Warimwe G
Austrian K
Barasa E
Vaccines (Basel), (2021). 9:
Tracking the introduction and spread of SARS-CoV-2 in coastal Kenya.Githinji G
de Laurent ZR
Mohammed KS
Omuoyo DO
Macharia PM
Morobe JM
Otieno E
Kinyanjui SM
Agweyu A
Maitha E
Kitole B
Suleiman T
Mwakinangu M
Nyambu J
Otieno J
Salim B
Kasera K
Kiiru J
Aman R
Barasa E
Warimwe G
Bejon P
Tsofa B
Ochola-Oyier LI
Nokes DJ
Agoti CN
Nat Commun, (2021). 12:4809
Urban Ecology of Arboviral Mosquito Vectors Along the Kenyan Coast.Karisa J
Muriu S
Omuoyo D
Karia B
Ngari M
Nyamwaya D
Rono M
Warimwe G
Mwangangi J
Mbogo CM
J Med Entomol, (2021). 58:428-438
Analysis of immunity to febrile malaria in children that distinguishes immunity from lack of exposure.Bejon P
Warimwe G
Mackintosh CL
Mackinnon MJ
Kinyanjui SM
Musyoki JN
Bull PC
Marsh K
Infect Immun, (2009). 77:1917-23
